Literature DB >> 998222

Haemorrhagic disease of the newborn in the offspring of rifampicin and isoniazid treated mothers.

E Eggermont, N Logghe, W Van De Casseye, M Casteels-Van Daele, J Jaeken, J Cosemans, M Verstraete, M Renaer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 998222

Source DB:  PubMed          Journal:  Acta Paediatr Belg        ISSN： 0001-6535


× No keyword cloud information.
  3 in total

1.  Severe coagulopathy caused by rifampicin in patients with primary sclerosing cholangitis and refractory pruritus.

Authors:  Fotios Sampaziotis; William J H Griffiths
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

2.  A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial.

Authors:  William M Hague; Leonie Callaway; Jennifer Chambers; Lucy Chappell; Suzette Coat; Jiska de Haan-Jebbink; Marloes Dekker; Peter Dixon; Jodie Dodd; Maria Fuller; Sanne Gordijn; Dorothy Graham; Oskari Heikinheimo; Annemarie Hennessy; Risto Kaaja; Teck Yee Khong; Laura Lampio; Jennie Louise; Angela Makris; Corey Markus; Hanns-Ulrich Marschall; Philippa Middleton; Ben W Mol; Jonathan Morris; John P Newnham; Caroline Ovadia; Michael Peek; Antonia Shand; Michael Stark; Jim Thornton; Susanna Timonen; Susan Walker; David Warrilow; Catherine Williamson
Journal:  BMC Pregnancy Childbirth       Date:  2021-01-12       Impact factor: 3.007

3.  Saudi guidelines for testing and treatment of latent tuberculosis infection.

Authors:  Hamdan H Al Jahdali; Salim Baharoon; Abdullah A Abba; Ziad A Memish; Abdulrahman A Alrajhi; Ali AlBarrak; Qais A Haddad; Mohammad Al Hajjaj; Madhukar Pai; Dick Menzies
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.